Development of carbohydrate based next-generation anti-pertussis vaccines
Authors:
- 17 October 2022
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 74, 117066
Abstract
No abstract availableKeywords
Funding Information
- Michigan State University
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI146210, R01AI153829, R21AI156732)
This publication has 84 references indexed in Scilit:
- Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine eraCarbohydrate Research, 2013
- Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis VaccinePLOS Pathogens, 2013
- Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccineProceedings of the National Academy of Sciences, 2011
- The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesinMolecular Microbiology, 2010
- Evidence for an intact polysaccharide capsule in Bordetella pertussisMicrobes and Infection, 2010
- Opportunities and challenges in synthetic oligosaccharide and glycoconjugate researchNature Chemistry, 2009
- Pertussis VaccineThe Pediatric Infectious Disease Journal, 2009
- Acellular Pertussis Vaccines and Complement Killing ofBordetella pertussisInfection and Immunity, 2004
- Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide AJournal of General Microbiology, 1991
- The Antigen of Bordetella pertussis that Induces Bactericidal Antibody and its Relationship to Protection of MiceJournal of General Microbiology, 1972